Looks like you are not TradeKey.com's Member yet. Signup now to connect with over 10 Million Importers & Exporters globally. Join Now, its Free |
BOOK A CALL
Book Call On Your Favorite Time
Code
🗘

By Signing Up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

Contact Us
product
Prev
Hyaluronic acid (HA)Successful Discussion on Clinical Trial Protocol
Next

Hyaluronic acid (HA)Successful Discussion on Clinical Trial Protocol

FOB Price

Get Latest Price

( Negotiable )

|

- Minimum Order

Country:

China

Model No:

-

FOB Price:

( Negotiable ) Get Latest Price

Place of Origin:

-

Price for Minimum Order:

-

Minimum Order Quantity:

-

Packaging Detail:

-

Delivery Time:

-

Supplying Ability:

-

Payment Type:

T/T

Product Group :

-

Contact Now
1st Year

Contact Person Ms. Angela Yan

Guoxiang Street, Wuzhong District, Suzhou City

Contact Now

Product Specification

  • Properties: Injection & Puncture Instrument

Product Description

Successful Discussion on Clinical Trial Protocol for PEG Embolic Microspheres in Uterine Fibroids Held in Suzhou
On August *7, ***4, a successful meeting was held at Suzhou Baodaiqiao International Hotel to discuss the clinical trial protocol for the treatment of symptomatic uterine fibroids using PEG (polyethylene glycol) embolization microspheres. The discussion, which was highly productive, focused on evaluating the efficacy and safety of PEG embolization microspheres in addressing this condition.
The PEG embolic microspheres from Suzhou Haowei offer a range of benefits that make them an ideal choice for the treatment of uterine fibroids. With a comprehensive range of specifications, the microspheres are available in sizes ranging in different sizes, ensuring uniform particle sizefor precise embolization. This precision helps to shorten surgery time, providing a significant advantage in clinical settings. The property of biodegradability ensures safety and effectiveness of the operation. Whats more, the embolic microspheres could loading a series of drug to enhance the operational effect in a comparatively short loading time.
Participants expressed confidence in the promising potential of this treatment, with the protocol receiving positive feedback from all involved. The clinical trial will involve multiple institutions across China, each playing a vital role in the research: Here are the lists:

Site Code Clinical Trial Site Department Investigator
*1 Beijing Obstetrics and Gynecology Hospital, Capital Medical University Department of Gynecologic Oncology Prof. Wang Jiandong
*2 The First Affiliated Hospital of Guangxi Medical University Department of Gynecology Dr. Fan Jiangtao
*3 Guangzhou Women and Children's Medical Center Department of Gynecology Dr. Huang Shenjiao
*4 Hangzhou First People's Hospital Department of Gynecology Dr. Tong Jinyi
*5 West China Second University Hospital, Sichuan University Department of Radiology Dr. Ning Gang
*6 The Second Affiliated Hospital of Soochow University Department of Interventional Radiology Dr. Jin Yong
*7 Suzhou Municipal Hospital Department of Vascular Surgery Dr. Zhou Dayong
*8 The Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University Department of Interventional Diagnosis and Treatment Dr. Si Guangyan
*9 Yantai Yuhuangding Hospital Department of Gynecology Dr. Wang Shaoguang
The study is sponsored by Suzhou Haowei Medical Technology Co., Ltd., and will be led by Professor Wang Jiandong as the principal investigator at the primary site.

Country: China
Model No: -
FOB Price: ( Negotiable ) Get Latest Price
Place of Origin: -
Price for Minimum Order: -
Minimum Order Quantity: -
Packaging Detail: -
Delivery Time: -
Supplying Ability: -
Payment Type: T/T
Product Group : -
Hyaluronic acid (HA)Successful Discussion on Clinical Trial Protocol

Send a direct inquiry to this supplier

To:

Ms. Angela Yan < Suzhou Haowei Medical Technology Co., Ltd >

I want to know: